Mingjie Xu

79 Qingchun Road
Hangzhou, 310000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Tumor suppressing function of SLC16A7 in bladder cancer and its pan-cancer analysis.

Tumor suppressing function of SLC16A7 in bladder cancer and its pan-cancer analysis.

Journal: BMC cancer

Published: December 09, 2024

Stomal variceal haemorrhage in ileal conduit diversion: a rare case report and literature review.

Stomal variceal haemorrhage in ileal conduit diversion: a rare case report and literature review.

Journal: Frontiers in oncology

Published: May 30, 2024

FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m6A dependent pathway.

FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m6A dependent pathway.

Journal: Cell death discovery

Published: March 30, 2022

miR-665 inhibits epithelial-to-mesenchymal transition in bladder cancer via the SMAD3/SNAIL axis.

miR-665 inhibits epithelial-to-mesenchymal transition in bladder cancer via the SMAD3/SNAIL axis.

Journal: Cell cycle (Georgetown, Tex.)

Published: July 01, 2021

YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.

YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.

Journal: Molecular cancer

Published: May 17, 2019

Dysregulation of ncRNAs located at the DLK1‑DIO3 imprinted domain: involvement in urological cancers.

Dysregulation of ncRNAs located at the DLK1‑DIO3 imprinted domain: involvement in urological cancers.

Journal: Cancer management and research

Published: January 31, 2019

Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.

Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.

Journal: Oncotarget

Published: August 23, 2017

MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop.

MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop.

Journal: Cell death & disease

Published: June 15, 2017

c-Met, CREB1 and EGFR are involved in miR-493-5p inhibition of EMT via AKT/GSK-3β/Snail signaling in prostate cancer.

c-Met, CREB1 and EGFR are involved in miR-493-5p inhibition of EMT via AKT/GSK-3β/Snail signaling in prostate cancer.

Journal: Oncotarget

Published: April 21, 2017

MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer.

MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer.

Journal: Cell death & disease

Published: March 22, 2017

Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer.

Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer.

Journal: Cell death & disease

Published: December 22, 2016

Distinct characterization of two vinorelbine-resistant breast cancer cell lines developed by different strategies.

Distinct characterization of two vinorelbine-resistant breast cancer cell lines developed by different strategies.

Journal: Oncology reports

Published: November 06, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026